Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.020
-0.150 (-3.60%)
Aug 14, 2025, 1:52 PM - Market open
Cytek Biosciences Employees
Cytek Biosciences had 648 employees as of December 31, 2024. The number of employees decreased by 28 or -4.14% compared to the previous year.
Employees
648
Change (1Y)
-28
Growth (1Y)
-4.14%
Revenue / Employee
$302,523
Profits / Employee
-$9,880
Market Cap
511.44M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 648 | -28 | -4.14% |
Dec 31, 2023 | 676 | 93 | 15.95% |
Dec 31, 2022 | 583 | 81 | 16.14% |
Dec 31, 2021 | 502 | 111 | 28.39% |
Dec 31, 2020 | 391 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CTKB News
- 1 day ago - Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 days ago - Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Cytek Biosciences Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer - GlobeNewsWire
- 2 months ago - Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cytek Biosciences Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued? - Seeking Alpha